[{"from": "human", "value": "Could you provide a description of this molecule? [C][C][=C][C][=C][Branch1][Ring2][N][Ring1][Branch1][C][=C][C][=Branch1][Branch1][=C][Ring1][#Branch1][F][O][C][=N][C][=N][N][C][Ring1][=Branch1][=C][Branch1][=C][C][=Branch1][Ring2][=C][Ring1][Branch1][O][C][C@@H1][Branch1][C][C][O][C]"}, {"from": "gpt", "value": "The molecule is a secondary alcohol resulting from the hydrolysis of the carboxylic ester group of brivanib alaninate. It is a dual VEGFR-2/FGFR-1 kinase inhibitor whose alanine prodrug, brivanib alaninate is currently under development as an oral agent for the treatment of cancer. It has a role as an antineoplastic agent, an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor, an angiogenesis inhibitor, an apoptosis inducer, a fibroblast growth factor receptor antagonist and a drug metabolite. It is a pyrrolotriazine, a fluoroindole, a diether, an aromatic ether and a secondary alcohol."}]